small molecule

VELTASSA

PATIROMER SORBITEX CALCIUM

Loss of exclusivityOctober 2033latest FDA-listed patent expiry

CompanyVifor Pharma →See this company's full patent-cliff portfolio

Drug detail

Brand name	VELTASSA
Active ingredient	PATIROMER SORBITEX CALCIUM
Strength	EQ 16.8GM BASE/PACKET
Dosage form	POWDER
Route	ORAL
Modality	Small molecule
FDA approval	October 2015
Marketing status	RX

Listed patents

Patent	Expires	Type
11123363	October 2033	use U-1766
9492476	October 2033	use U-1766
9925212	October 2033	use U-1766
8337824	May 2030	substance
8147873	June 2028	product
8282913	May 2027	product
8216560	March 2027	use U-1766

Regulatory exclusivity

Code	Expires
NPP	October 2026

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Drug detail

Listed patents

Regulatory exclusivity

More from Vifor Pharma